Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Recce Pharmaceuticals Ltd RECEF

Set alert

Price alert · RECEF

All alert types
0.22 USD 0.00 0.00%

At close · Oct 30

0.60 Day range 0.60
0.22 52-week range 0.60
YTD
0.00%
1 year
0.00%
Open
0.60
Prev close
0.22
Mkt cap
67.27M
Vol
60
Avg vol
0
EPS
-0.06
P/E
0.00
More statistics
Low
0.60
High
0.60

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for RECEF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-24.47 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -5.9×
FY 2017: -19.9×FY 2018: -41.3×FY 2019: -29.5×FY 2020: -25.9×FY 2021: -9.3×FY 2022: -13.9×FY 2023: -12.1×FY 2024: -9.0×FY 2025: -3.7×FY 2026: -5.9×
FY 2017 5y median -9.0× FY 2026
P/S 0.0×
FY 2017: 433×FY 2018: 53.8×FY 2019: 121×FY 2020: 99.5×FY 2021: 76.7×FY 2022: 49.5×FY 2023: 36.2×FY 2024: 23.3×FY 2025: 10.5×FY 2026: 0.0×
FY 2017 5y median 23.3× FY 2026
P/B -5.5×
FY 2017: 102×FY 2018: 99.8×FY 2019: -203×FY 2020: 48.3×FY 2021: 6.1×FY 2022: 15.2×FY 2023: -61.1×FY 2024: -16.7×FY 2025: -26.0×FY 2026: -5.5×
FY 2017 5y median -16.7× FY 2026
P/FCF -8.9×
FY 2017: -22.0×FY 2018: -36.3×FY 2019: -30.4×FY 2020: -29.3×FY 2021: -15.8×FY 2022: -16.9×FY 2023: -12.4×FY 2024: -12.1×FY 2025: -3.9×FY 2026: -8.9×
FY 2017 5y median -12.1× FY 2026
EV/EBITDA -4.2×
FY 2017: -18.8×FY 2018: -24.0×FY 2019: -30.8×FY 2020: -21.3×FY 2021: -7.1×FY 2022: -13.1×FY 2023: -9.2×FY 2024: -7.3×FY 2025: -4.0×FY 2026: -4.2×
FY 2017 5y median -7.3× FY 2026
EV/Sales 0.0×
FY 2017: 426×FY 2018: 53.3×FY 2019: 121×FY 2020: 97.2×FY 2021: 64.0×FY 2022: 45.8×FY 2023: 35.9×FY 2024: 22.8×FY 2025: 10.6×FY 2026: 0.0×
FY 2017 5y median 22.8× FY 2026
FCF Yield -11.2%
FY 2017: -4.6%FY 2018: -2.8%FY 2019: -3.3%FY 2020: -3.4%FY 2021: -6.3%FY 2022: -5.9%FY 2023: -8.0%FY 2024: -8.2%FY 2025: -25.8%FY 2026: -11.2%
FY 2017 5y median -8.2% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 81.7%FY 2018: 95.9%FY 2019: 91.7%FY 2020: 82.1%FY 2021: 81.9%FY 2022: 93.9%FY 2023: 95.0%FY 2024: -5.4%FY 2025: -39.1%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017: -2286.2%FY 2018: -226.7%FY 2019: -503.1%FY 2020: -482.1%FY 2021: -938.4%FY 2022: -458.7%FY 2023: -396.9%FY 2024: -321.9%FY 2025: -304.7%FY 2026: 0.0%
FY 2017 5y median -321.9% FY 2026
Net Margin 0.0%
FY 2017: -2172.0%FY 2018: -129.9%FY 2019: -410.4%FY 2020: -384.8%FY 2021: -825.3%FY 2022: -356.1%FY 2023: -299.6%FY 2024: -257.8%FY 2025: -285.4%FY 2026: 0.0%
FY 2017 5y median -285.4% FY 2026
ROE 92.9%
FY 2017: -512.7%FY 2018: -240.9%FY 2019: 687.7%FY 2020: -186.7%FY 2021: -65.9%FY 2022: -109.2%FY 2023: 505.2%FY 2024: 185.4%FY 2025: 702.1%FY 2026: 92.9%
FY 2017 5y median 185.4% FY 2026
ROIC 247.8%
FY 2017: -393.2%FY 2018: -226.0%FY 2019: -711.8%FY 2020: -177.4%FY 2021: -66.5%FY 2022: -107.8%FY 2023: 607.1%FY 2024: 203.6%FY 2025: -225.9%FY 2026: 247.8%
FY 2017 5y median 203.6% FY 2026
ROA -182.1%
FY 2017: -206.6%FY 2018: -146.4%FY 2019: -302.5%FY 2020: -133.1%FY 2021: -62.3%FY 2022: -87.0%FY 2023: -511.7%FY 2024: -277.3%FY 2025: -172.6%FY 2026: -182.1%
FY 2017 5y median -182.1% FY 2026

Growth (YoY)

Revenue -100.0%
FY 2017: -21.3%FY 2018: 825.0%FY 2019: -47.3%FY 2020: 65.1%FY 2021: 46.0%FY 2022: 88.4%FY 2023: 41.5%FY 2024: 56.9%FY 2025: 9.6%FY 2026: -100.0%
FY 2017 FY 2026
Operating Income -4.9%
FY 2017: 33.9%FY 2018: 8.3%FY 2019: -17.1%FY 2020: -58.2%FY 2021: -184.1%FY 2022: 7.9%FY 2023: -22.4%FY 2024: -27.3%FY 2025: -3.8%FY 2026: -4.9%
FY 2017 FY 2026
EPS (diluted) 40.7%
FY 2017: 54.1%FY 2018: 49.9%FY 2019: -49.0%FY 2020: -15.1%FY 2021: -156.3%FY 2022: 27.4%FY 2023: -19.0%FY 2024: -34.0%FY 2025: 9.3%FY 2026: 40.7%
FY 2017 FY 2026
Free Cash Flow 49.6%
FY 2017: -62.8%FY 2018: 30.4%FY 2019: -41.5%FY 2020: -41.1%FY 2021: -108.0%FY 2022: -14.1%FY 2023: -40.6%FY 2024: -3.3%FY 2025: -55.6%FY 2026: 49.6%
FY 2017 FY 2026

Financial Health

Current Ratio 0.4×
FY 2017: 1.7×FY 2018: 1.7×FY 2019: 0.4×FY 2020: 3.1×FY 2021: 19.6×FY 2022: 5.0×FY 2023: 0.4×FY 2024: 0.3×FY 2025: 1.9×FY 2026: 0.4×
FY 2017 5y median 0.4× FY 2026
Quick Ratio 0.4×
FY 2017: 1.8×FY 2018: 1.8×FY 2019: 0.4×FY 2020: 3.1×FY 2021: 19.6×FY 2022: 5.0×FY 2023: 0.4×FY 2024: 0.3×FY 2025: 1.9×FY 2026: 0.4×
FY 2017 5y median 0.4× FY 2026
Debt / Equity -0.6×
FY 2017: 0.3×FY 2018: 0.0×FY 2019: -1.8×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -0.1×FY 2024: -0.1×FY 2025: -3.5×FY 2026: -0.6×
FY 2017 5y median -0.1× FY 2026
Net Debt / EBITDA -0.3×
FY 2017: 0.3×FY 2018: 0.2×FY 2019: -0.1×FY 2020: 0.5×FY 2021: 1.4×FY 2022: 1.1×FY 2023: 0.1×FY 2024: 0.2×FY 2025: -0.0×FY 2026: -0.3×
FY 2017 5y median 0.1× FY 2026
Interest Coverage -14.0×
FY 2017: -1324×FY 2018: -53.8×FY 2019: -60.3×FY 2020: -95.8×FY 2021: -1266×FY 2022: -1187×FY 2023: -94.5×FY 2024: -26.0×FY 2025: -19.9×FY 2026: -14.0×
FY 2017 5y median -26.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30